Fiducial markers are small reference markers used in medical imaging, such as X-rays, CT scans, and MRI, to help identify specific points in images. They are typically made of materials that are visible on the image, such as gold or other metals. The market for fiducial markers is growing, driven by increasing demand for medical imaging in the diagnosis and treatment of various diseases and conditions, such as cancer, neurological disorders, and cardiovascular diseases. The increasing use of image-guided procedures, such as radiation therapy and minimally invasive surgical procedures, is also driving demand for fiducial markers.
In addition, the development of new and improved fiducial markers, such as those made from biodegradable materials, is expected to fuel growth in the market. Furthermore, the growing use of 3D imaging and computer-aided diagnosis is also expected to drive demand for fiducial markers. However, factors such as the high cost of fiducial markers and the lack of standardization in their use across different medical imaging modalities may hinder market growth.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=1026
Segmentation of Fiducial Marker Industry Research
- By Product Type :
- Polymer-based Markers
- Metal-based Markers
- Pure Gold Markers
- Liquid-based Markers
- By Modality :
- Photon Therapy
- Proton Therapy
- Tomotherapy
- Cyberknife
- By Disease Site :
- Head & Neck
- Breast
- Lung
- Abdomen
- Prostate
- Kidney
- Cervix or Other Gynaecologic Organs
- By End User :
- Hospitals
- Cancer Research Institutes
- Radiotherapy Centers
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & ASEAN
- Oceania
- MEA
Competitive Landscape
The majority of manufacturers of fiducial markers are working to diversify their product lines. The marketing of the product through online portals, however, is the most important strategy for expanding the customer base. Making the product available online is another factor that is anticipated to fuel market expansion.
- SBRT Immobilization, Supine Breast & Thorax Positioning, and other fiducial markers were introduced by Innovative Oncology Solutions in 2020.
- A wide variety of new fiducial markers, including the SolsticeTM MR SRS Immobilization System, MonarchTM Vac-LokTM Options, and others, were introduced by CIVCO in 2020.
Key Companies Profiled
- Eckert & Ziegler BEBIG
- Innovative Oncology Solutions
- Boston Scientific
- IBA Dosimetry
- Best Medical International, Inc.
- IZI Medical Products
- Carbon Medical Technologies
- CIVCO
-
alphaXRT
